Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 15, Number 6—June 2009

Dispatch

Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe

Ioannis D. Xynos, Maria G. Tektonidou, Dimitrios Pikazis, and Nikolaos V. SipsasComments to Author 
Author affiliations: National and Kapodistrian University of Athens, Athens, Greece (I.D. Xynos, D. Pikazis, N.V. Sipsas); Euroclinic Hospital of Athens, Athens (M.G. Tektonidou)

Main Article

Figure

Reported cases of leishmaniasis in patients with autoimmune rheumatic diseases in Europe, indicated by stars (1 case from Israel not shown). Dark gray shading, distribution of leishmaniasis; light gray shading, distribution of leishmaniasis vector sandfly. Source: World Health Organization, 2004 (www.who.int/tdr/svc/publications/tdr-research-publications/swg-report-leishmaniasis).

Figure. Reported cases of leishmaniasis in patients with autoimmune rheumatic diseases in Europe, indicated by stars (1 case from Israel not shown). Dark gray shading, distribution of leishmaniasis; light gray shading, distribution of leishmaniasis vector sandfly. Source: World Health Organization, 2004 (www.who.int/tdr/svc/publications/tdr-research-publications/swg-report-leishmaniasis).

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external